TP53 and hepatocellular carcinoma: Strikingly, genomic profiling of UTUC and hepatocellular carcinoma (HCC) samples from Taiwan, the Balkans, and Belgium have consistently revealed an enriched SBS22 signature (AA-UTUC), including the well-known tumor suppressor gene TP53, implicating the strong mutagenic effect by AA [36,37,38].